N/A
N=32
Magnetic Resonance Imaging in Subjects With Gouty Tophi
Hyperuricemia · Gout
Bottom Line
View on ClinicalTrials.gov: NCT00174954 ↗Enrolled (actual)
32
Serious AEs
6.3%
Results posted
Jul 2009
Primary outcome: Primary: Measurement of Tophi by MRI - Difference in Volument Between Visits — -0.05 centimeters³ (cm³) — p=0.785
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- MRI (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Takeda
- Primary completion
- Jan 2003
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Measurement of Tophi by MRI - Difference in Volument Between Visits |
-0.05 | 0.785 |
| PRIMARY Measurement of Tophi by MRI - Difference in Volume Between Readers |
0.89 | 0.020 sig |
Summary
The purpose of this study is to determine the reproducibility of Magnetic Resonance Imaging (MRI) in the quantitative assessment of tophus volume.
Eligibility Criteria
Inclusion Criteria
- Subjects with gout and at least one tophi.
Exclusion Criteria
- Unable to undergo MRI.
Data sourced from ClinicalTrials.gov (NCT00174954). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.